ARTICLE | Clinical News

Fusidic acid: Phase I data

November 9, 2009 8:00 AM UTC

A Phase I trial in 69 healthy volunteers showed that a loading dose of at least 1,200 mg CEM-102 twice daily on the first treatment day followed by 600 mg twice daily on subsequent days optimized the ...